Startup based in the United States, 1 tracked investor.
Based in the United States, Valitor is a startup founded in 2020. Brouky records 1 investor associated with the company.
Valitor develops biopharmaceuticals using a proprietary platform technology from UC Berkeley, focusing on long-acting anti-VEGF therapies for exudative retinal diseases as well as treatments in immuno-oncology and inflammatory joint diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.